Both Phrma (the lobby for the global pharmaceutical industry) and Biotechnology Innovation Organization (biotech lobbyists) provided letters to a US-UK government meeting to discuss post-Brexit trade terms, in which both organisations called for substantially higher British prices for essential medicines after Brexit. Read the rest